Omalizumab had the greatest risk for adverse effects and dupilumab had the most favorable safety profile among biologics for patients with asthma, according to an abstract presented at the CHEST ...
Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment ...
Dr Punam Krishan has given a warning to anyone who is using specific medications for heart issues or bad circulation. On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback